Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells.
about
Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubulesResistance to platinum-based chemotherapy in lung cancer cell lines.Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells.Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha.Modulation of cis-diamminedichloroplatinum(II) resistance: a review.Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitroExposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer.Enhancement of drug sensitivity of human malignancies by epidermal growth factor.Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines.Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.Expression of the zinc finger gene EVI-1 in ovarian and other cancers.Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells.Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.Cellular accumulation of the anticancer agent cisplatin: a review.N1,N12-bis(ethyl)spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines.Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).Reversal of radiation-induced cisplatin resistance in murine fibrosarcoma cells by selective modulation of the cyclic GMP-dependent transduction pathway.Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo.Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers.Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice.Alteration of type II regulatory subunit of cAMP-dependent protein kinase in human cisplatin-resistant cells as a basis of collateral sensitivity to 8-chloro-cAMP.
P2860
Q33755882-0F9E6FFB-B3E6-4863-A352-8C5B60C32864Q34114078-272B5C91-96B5-48DA-BAEC-831AAD427A00Q34214006-CC63385B-7247-4388-B84C-377B9211D05FQ35553372-4CC028B2-8AF6-4C0E-B5B2-80911CCA3C45Q35606961-29988CF1-D1C8-46CD-BC69-7C93D14B4B1AQ35707858-3D1B017E-62C7-4074-A779-432A9A8FC287Q35976136-C81285B6-A734-40C5-A99F-218E4DA2F346Q35977724-3E231A72-A8F0-4DEA-BB41-06F27B5B5C22Q35997145-1064F2E7-F480-4D53-A879-81837FBC8D2CQ36081127-9CD28880-830E-4809-8ECD-E6C6DEB08B2EQ36116265-71A7E9ED-C98D-4706-A9CF-30AF5C1FA63EQ36136501-32F04E86-0F07-49BA-8BF3-CEF3BA89ADFEQ36136599-9C2604D0-C97F-4C16-85D1-7EFB4C2257FFQ38276429-EE73C269-1207-46B5-8A2F-5F5D8045FE91Q40751233-D62E0BC9-DB6C-45EE-BFF2-FA68D4814D02Q40849899-944444F2-ACA2-4446-97C3-5B30D65A9CDFQ40917698-FC39AF49-0C24-4143-956D-DE76B36B3E2CQ41011338-384F6852-575F-49A6-B443-879ABD814EDAQ41254059-E0C00E42-1E89-4E69-B31F-56EF3846708FQ41582980-B3F7C65B-B39F-42C2-97FB-77B7D93C7CF3Q42146868-54448144-CE10-4324-AD27-FD08B1924A42Q42590267-A56BE36E-C85B-4F74-878E-4A807AFBE861Q53264975-6C86AB31-75C4-4D64-8530-FA954F7B7C31Q54284519-54A046B6-7D5C-4F89-8B3E-75ADD29277B0Q55396947-EA72DFFE-7687-43C2-B081-90DFD7B238E2
P2860
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Modulation of cis-diamminedich ...... human ovarian carcinoma cells.
@en
type
label
Modulation of cis-diamminedich ...... human ovarian carcinoma cells.
@en
prefLabel
Modulation of cis-diamminedich ...... human ovarian carcinoma cells.
@en
P2093
P2860
P356
P1476
Modulation of cis-diamminedich ...... human ovarian carcinoma cells.
@en
P2093
P2860
P304
P356
10.1002/IJC.2910480613
P577
1991-07-01T00:00:00Z